[Acute toxicity after hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer]
- PMID: 26545765
- DOI: 10.1007/s00066-015-0924-1
[Acute toxicity after hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer]
Comment on
-
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.Lancet Oncol. 2015 Mar;16(3):274-83. doi: 10.1016/S1470-2045(14)70482-6. Epub 2015 Feb 3. Lancet Oncol. 2015. PMID: 25656287 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical